Prestige Consumer Healthcare Cuts Fiscal 2027 Revenue and EPS Outlook
Photo: TokenPost
Prestige Consumer Healthcare lowered its fiscal 2027 revenue and adjusted earnings forecasts after Pillar5 production variability was expected to reduce Clear Eyes availability and revenue during the second half of fiscal 2027. The Nov. 5 revision puts revenue at $1.280 billion to $1.290 billion, down from $1.290 billion to $1.315 billion. Adjusted diluted earnings per share (EPS) is now forecast at $4.48 to $4.55, compared with $4.55 to $4.65. The company also moved its organic revenue growth outlook from 1% to 3% to roughly flat and lowered its adjusted free cash flow target to at least $265 million from at…
Source: TokenPost
